Top Markets
#1 Siacoin Siacoin +18.72%
#2 Cash Cat Cash Cat +12.00%
#3 Seeker Seeker +10.47%
#4 DogBull DogBull +9.87%
#5 0G 0G +7.70%
#6 Story Story +5.49%
#7 The Black Bull The Black Bull +5.17%
#8 Useless Coin Useless Coin +5.06%
#9 The Bitcoin Bull The Bitcoin Bull +4.99%
#10 Linea Linea +4.75%
Coin of the day
Siacoin Siacoin
설정
언어
한국어
통화
USD
테마
Nika Pharmaceuticals Inc. Nika Pharmaceuticals Inc.

Nika Pharmaceuticals Inc.

NIKA
주식 순위 #14188
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in... Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.
주가
$0.41
마지막 동기화: 2026-08-28
시가총액
$429.91M
변동 (1일)
0.00%
변동 (1년)
-56.72%
국가
US
거래 Nika Pharmaceuticals Inc. (NIKA)

카테고리

Healthcare
Nika Pharmaceuticals Inc. (NIKA)의 주식 분할 이력
Nika Pharmaceuticals Inc. 주식 (심볼: NIKA)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Sep 01, 2026에 발생했습니다.
Sep 01, 2026 이전에 매수한 NIKA 주식 1주는 현재 0주의 NIKA 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 0 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 0 -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 0 -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5 x119
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 0 -
CH